Systematic review of the effects of pertussis vaccines in children

Tom Jefferson1, Melanie Rudin, Carlo DiPietrantonj

  • 1Health Reviews Ltd., Via Adige 28a, 00061 Anguillara Sabazia, Rome, Italy. toj1@aol.com

Vaccine
|April 23, 2003
PubMed

Insights

Both whole-cell and acellular pertussis vaccines are effective. Acellular vaccines with three or more components offer higher efficacy and a better safety profile than whole-cell vaccines.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Pertussis, also known as whooping cough, is a highly contagious respiratory infection.
  • Vaccination is the primary strategy for preventing pertussis.
  • Whole-cell and acellular pertussis vaccines are available, often administered within diphtheria, tetanus, and pertussis (DTP) combination vaccines.

Purpose of the Study:

  • To evaluate the effectiveness and safety of whole-cell and acellular pertussis vaccines.
  • To compare different types of pertussis vaccines, including those with varying antigenic components.
  • To assess adverse events associated with pertussis vaccination in children.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs) and cohort studies.
  • Searched major scientific databases (Cochrane Library, MEDLINE, EMBASE, etc.) up to December 2001.
  • Included studies comparing pertussis vaccines against placebo, DT vaccine, or each other.

Main Results:

  • All tested whole-cell and acellular pertussis vaccines demonstrated significant efficacy compared to placebo.
  • Whole-cell DTP vaccines showed variable efficacy (37-92%).
  • Acellular vaccines with three or more components had higher efficacy (80-84%) than those with one or two components (67-70%).
  • Whole-cell vaccines were linked to increased local reactions, fever, and prolonged crying.
  • Acellular vaccines had a similar adverse event profile to placebo and were safer than whole-cell vaccines.

Conclusions:

  • All evaluated pertussis vaccines are efficacious in preventing pertussis.
  • Acellular pertussis vaccines containing three or more antigenic components exhibit superior efficacy compared to those with fewer components.
  • Acellular pertussis vaccines possess a more favorable safety profile than whole-cell pertussis vaccines.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...